ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut radiation plus immunotherapy may turn inoperable esophageal cancer into a surgical target
Disease control OngoingThis study tests whether adding a single, low dose of radiation to the small intestine can boost the power of immunotherapy and chemotherapy to shrink esophageal tumors that are too advanced for surgery. About 43 adults with borderline or unresectable esophageal squamous cell car…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE2 • Sponsor: Chuangzhen Chen • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Immunotherapy boosts Chemo-Radiation for esophageal cancer in major trial
Disease control OngoingThis phase 3 trial tests whether adding the immunotherapy drug pembrolizumab to standard chemoradiotherapy helps people with advanced esophageal cancer live longer or delay the cancer from coming back. About 700 participants who cannot have surgery will receive either pembrolizum…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Scientists map hidden spread of esophageal cancer
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at tissue samples from 30 people with esophageal cancer to see how far the cancer cells spread beyond what the surgeon can see. The goal is to better understand these hidden patterns so doctors can remove all the cancer during surgery. Participants are adults wit…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Sponsor: Shanghai Chest Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
French study tracks Real-World results of combo therapy for stomach cancer
Knowledge-focused OngoingThis study follows 208 adults in France who are already receiving nivolumab combined with chemotherapy as their first treatment for advanced or metastatic stomach, gastroesophageal junction, or esophageal cancers. The goal is to see how long patients live and how the disease resp…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC